CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells

Biochemical and Biophysical Research Communications

Volumn 383, Issue 2, 2009, Pages 172-177

  Yamazaki, Hiroto ^a   Nishida, Hiroko ^a   Iwata, Satoshi ^a   Dang, Nam H ^b   Morimoto, Chikao ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b NEVADA CANCER INSTITUTE   (United States)

Author keywords

Cancer stem cells; CD110; CD90; T acute lymphoblastic leukemia

Indexed keywords

MEMBRANE ANTIGEN; THROMBOPOIETIN RECEPTOR; THY 1 ANTIGEN; TUMOR MARKER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CELL HETEROGENEITY; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL LEUKEMIA; T LYMPHOCYTE;

ANIMALS; ANTIGENS, THY-1; CELL LINE; CELL LINE, TUMOR; CELL SEPARATION; HUMANS; MICE; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, THROMBOPOIETIN;

EID: 65049090853     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.127     Document Type: Article

References (22)

1. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
2. Passegue E., Jamieson C.H.M., Ailles L.E., and Weissman I.L. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?. Proc. Natl. Acad. Sci. USA 100 (2003) 11842-11849
3. Wang J.C.Y., and Dick J.E. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 15 (2005) 494-501
4. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 (1997) 730-737
5. Ailles L.E., and Weissman I.L. Cancer stem cells in solid tumors. Curr. Opin. Biotechnol. 18 (2007) 460-466
6. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.M.H., Jones D.L., Visavadar J., Weissman I.L., and Wahl G.M. Cancer stem cells-perspectives on current status and future direction: AACR workshop on cancer stem cells. Cancer Res. 66 (2006) 9339-9344
7. Blair A., Hogge D.E., Ailles L.E., Lansdorp P.M., and Sutherland H.J. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 89 (1997) 3104-3112
8. Blair A., and Sutherland H.J. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Exp. Hematol. 28 (2000) 660-671
9. Hosen N., Park C.Y., Tatsumi N., Oji Y., Sugiyama H., Gramatzki M., Krensky A.M., and Weissman I.L. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 104 (2007) 11008-11013
10. Jordan C.T., Upchurch D., Szilvassy S.J., Guzman M.L., Howard D.S., Pettigrew A.L., Meyerrose T., Rossi R., Grimes B., Rizzieri D.A., Luger S.M., and Phillips G.L. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogeneous leukemia stem cells. Leukemia 14 (2000) 1777-1784
11. Matsui W., Huff C.A., Wang Q., Malehorn M.T., Barber J., Tanhehco Y., Smith B.D., Civin C.I., and Jones R.J. Characterization of clonogenic multiple myeloma cells. Blood 103 (2004) 2332-2336
12. Kayo H., Yamazaki H., Nishida H., Dang N.H., and Morimoto C. Stem cell properties and the side population cells as a target for interferon-α in adult T-cell leukemia/lymphoma. Biochem. Biophys. Res. Commun. 364 (2007) 808-814
13. Cox C.V., Evely R.S., Oakhill A., Pamphilon D.H., Goulden N.J., and Blair A. Characterization of acute lymphoblastic leukemia progenitor cells. Blood 104 (2004) 2919-2925
14. Cox C.V., Martin H.M., Kearns P.R., Virgo P., Evely R.S., and Blair A. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. Blood 109 (2007) 674-682
15. Viseur C., Hotfilder M., Bomken S., Wilson K., Rottgers S., Schrauder A., Rosemann A., Irving J., Stam R.W., Shultz L.D., Harbott J., Jurgens H., Schrappe M., Pieters R., and Vormoor J. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell 14 (2008) 47-58
16. Nishida H., Yamazaki H., Yamada T., Iwata S., Nam H.D., Inukai T., Sugita K., Ikeda Y., and Morimoto C. CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia. Biochem. Biophys. Res. Commun. 382 (2009) 57-62
17. Abkowitz J.L., and Chen J. Studies of c-Mpl function distinguish the replication of hematopoietic stem cells from the expansion of differentiating clones. Blood 109 (2007) 5186-5190
18. null mice model. Blood 102 (2003) 873-880
19. Masson N.M., Currie I.S., Terrace J.D., Garden O.J., Parks R.W., and Ross J.A. Hepatic progenitor cells in human fetal liver express the oval cell marker Thy-1. Am. J. Physiol. Gastrointest. Liver Physiol. 291 (2006) G45-G54
20. Oishi K., and Ito-Dufros Y. Angiogenic potential of CD44+ CD90+ multipotent CNS stem cells in vitro. Biochem. Biophys. Res. Commun. 349 (2006) 1065-1072
21. Jin L., Hope K.J., Zhai Q., Smadja-Joffe F., and Dick J.E. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat. Med. 12 (2006) 1167-1174
22. Krause D.S., Lazarides K., von Andrian U.H., and Van Etten R.A. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat. Med. 12 (2006) 1175-1180